Jordan Silverstein

Investor Relations Kontakt bei IMMATICS N.V.

Vermögen: 2 Mio $ am 30.04.2024

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Jordan Silverstein

Unternehmen	Position	Beginn	Ende
IMMATICS N.V.	Investor Relations Kontakt	01.09.2019	-
MacroChem Corp. MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI.	Investor Relations Kontakt	-	-
The Golf Championships, Inc.	Investor Relations Kontakt	25.07.2011	-

Unternehmen	Position	Beginn	Ende
INFLARX N.V.	Corporate Officer/Principal	01.09.2018	01.05.2021
ADVANCED ACCELERATOR APPLICATION SA(ADR)	Investor Relations Kontakt	01.05.2014	01.08.2018
DOMARK INTERNATIONAL INC	Investor Relations Kontakt	26.07.2011	-
DOMARK INTERNATIONAL INC	Public Communications Contact	26.08.2011	-

Champlain College

Undergraduate Degree

International

Operativ

Investor Relations Contact	5
Public Communications Contact	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
INFLARX N.V.	Health Technology
IMMATICS N.V.	Health Technology

Private Unternehmen	4
MacroChem Corp. MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI.	Health Technology
Advanced Accelerator Applications SA Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France.	Health Technology
DoMark International, Inc. DoMark International, Inc. Miscellaneous Commercial ServicesCommercial Services DoMark International, Inc. operates as a smartphone, tablet, gaming accessories and technology company. The company was founded on March 30, 2006 and is headquartered in London, the United Kingdom.	Commercial Services
The Golf Championships, Inc.